SEC Form 4 · accession 0001104659-15-044670
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Aldrich
Director
Period of report
Jun 8, 2015
Accepted (ET)
Jun 10, 2015 · 6:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 8, 2015 | M | 7,000 | $10.85 | A | 7,000 | D | |
| Common StockF2 | Jun 8, 2015 | S | 6,896 | $55.65 | D | 104 | D | |
| Common StockF3 | Jun 8, 2015 | S | 104 | $56.05 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4 | $10.85 | Jun 8, 2015 | M | 7,000 | D | — | Jun 9, 2025 | Common Stock | 7,000 | 13,000 | D |
| Stock Option (Right to Buy) | $27.05 | holding | — | — | — | Jan 28, 2015 | Jan 27, 2024 | Common Stock | 10,000 | 10,000 | D |
| Stock Option (Right to Buy) | $51.00 | holding | — | — | — | Jan 2, 2016 | Jan 1, 2025 | Common Stock | 12,000 | 12,000 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person.
- F2This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $55.05 to $56.04 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $56.05 to $56.08 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F4This option was granted on May 15, 2013 and vests over three years, with 8.33% of the shares underlying the option vested on August 15, 2013 and an additional 8.33% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter.